Sander, P <br/><br/>
Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model.  [electronic resource] 

 -  Infection and immunity  Jun 2001 
 - 3562-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0019-9567 
<br/><br/><label>Standard No.: </label>10.1128/IAI.69.6.3562-3568.2001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkylating Agents--pharmacology<br/>Animals<br/>Anti-Bacterial Agents--pharmacology<br/>Blotting, Western<br/>DNA Damage--drug effects<br/>DNA Repair--drug effects<br/>Drug Resistance, Microbial<br/>Gene Deletion<br/>Metronidazole--pharmacology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mycobacterium bovis--drug effects<br/>Rec A Recombinases--genetics<br/>Ribosomal Proteins--genetics<br/>Transformation, Bacterial<br/>Tuberculosis--microbiology<br/>Ultraviolet Rays<br/>Virulence